A proven solution for large-scale production of cells, vaccines, and cellular therapeutics, these systems have the same growth kinetics as laboratory-scale cell culture products. The ports of the system make it easy to customize and close, with custom tubing assemblies that facilitate venting, filling, and harvesting.
Used Alexanderwerk roller compactor, model WP200VN, stainless steel cosntruction, 200 mm diameter x 75 mm faced rolls, cored rolls, nominally rated up to 400 kg/hr, with twin screw feeder with agitated feed hopper, cantilevered rolls, with flake crusher, pre granulator and fines granulator, on board hydraulic unit, cabinet design, 480 volt, serial# 054-00116, built 2004.
Genevac HT series evaporators are the ideal solution for parallel evaporation bottlenecks in high throughput and production laboratories having high performance and high sample capacities.
For 50 years, WIRB-Copernicus Group has stood as the gold standard of ethical and regulatory human research oversight, with more years of IRB and IBC experience and more deep, trusted relationships with sponsors, CROs, institutions, and investigators.
The safe and reliable sterilization and depyrogenation of pre-cleaned containers is the most important pre-treatment step in the pharmaceutical process. The modular HQL 6000,7000 and 8000 tunnel series offer maximum process safety and reproducible treatment quality combined with high flexibility, cost effectiveness and efficiency.
What are the things that high-performing clinical research sites do that make sponsors return to them again and again?
Each year, approximately 16 percent of patients in United States hospitals are readmitted within 30 days of discharge. Readmissions and the additional treatments they entail are costly to both patients and insurers. Increasingly, they are costly to hospitals as well. A portion of readmissions are considered unavoidable, such as a planned readmission for chemotherapy, or an unexpected adverse event unrelated to the original diagnosis. However, many other readmissions are considered preventable through high quality clinical care and effective patient education and discharge procedures.
Review the need for rater training in clinical trials and review publications that report data on rater characteristics, training modalities and outcomes in terms of accuracy and reliability of clinical outcomes data.
When you pass a magnet over the surface of ferrofluid, it begins to reach out with its gooey, spikey arms. A team of researchers at Juniata College is using a Phantom high-speed camera to study its unique, magnetic particles that have vast implications for future lab-on-a-chip devices.
One area coming under increased regulatory scrutiny is change control: the ability to manage deviations to established policies and procedures in a way that is efficient, timely and compliant.
A study needed to enroll approximately 12,000 subjects and was also unique because it required subjects to self-collect samples at home. Read about the risk management and mitigation that Health Decisions utilized to keep the study on track.
A biopharmaceutical company wanted to determine whether patients treated with an oral inhibitor of phosphodieasterase-4 (PDE-4) would show improvement in signs and symptoms of PsA. They used ERT eCOA tablets to collect data about patient symptoms as observed by physicians through the ACR assessment which was used to assess efficacy. Results showed reduced monitoring time and costs, decreased time to database lock, and FDA approval.
There is an increasing need for objectivity in mapping and analyzing of lesions to create confidence in trial findings, reproducibility and translation to clinical practice for dermatology sponsors, regulators and clinicians. This paper examines evolving diagnostic practices coupled with advancing technology and their application to reduce subjectivity in dermatology clinical trials.
A large treatment plant includes several treatment processes that contribute to providing quality recycled water pursuant to the state of California Title 22 regulations. Major treatment processes include raw wastewater pumping, preliminary treatment, primary treatment, secondary treatment, tertiary treatment with Parkson DynaSand® filters, and disinfection.
Today, construction firms are faster to recognize the benefits of innovative technology, says Solibri Product Manager Juan Rodriguez. But the far-reaching nature of Solibri’s users – professionals in multiple disciplines, on every continent – has made it hard to get timely and complete customer feedback. Solibri wanted a much better understanding of how our typical users are engaging with the software through anonymous usage data. If they created a new feature, was it successful? Has it been adopted? Why, or why not?”
Ensuring that studies meet the business goals of sponsors and increase the range of treatment options available to patients and healthcare providers can be challenging when a trial must enroll subjects with a bothersome health condition and ask them to risk randomization to placebo. The project team in a study of an investigational treatment for bacterial vaginosis addressed such challenges and enabled the study to meet the sponsor’s goals.
Regulatory approval of a biosimilar requires comprehensive knowledge of both the process and the molecule while process development with the end goal in mind will help to achieve a robust manufacturing process.
The Orange County Water District (OCWD; the District) Board of Directors voted to award the contract to construct the 30 million gallon per day (MGD) Final Expansion of the world-renowned Groundwater Replenishment System (GWRS) to Shimmick Construction Company, Inc.
Following the Global Alliance for Banking on Values (GABV) Summit in Vancouver, Vancity has committed to a concerted, global effort among banking institutions to track and monitor the carbon impact of their portfolio of loans and investments within a period of three years
The U.S. Environmental Protection Agency (EPA) announced the availability of funding that could provide as much as $5.5B in loans, which could leverage over $11B in water infrastructure projects through the Water Infrastructure Finance and Innovation Act (WIFIA) program.
Recently, the U.S. Environmental Protection Agency (EPA) issued its first-ever loan from the Water Infrastructure Finance and Innovation Act (WIFIA) program to King County, Washington, to help finance its Georgetown Wet Weather Treatment Station.
Recently, the U.S. Environmental Protection Agency (EPA) announced a $47.7M Water Infrastructure Finance and Innovation Act (WIFIA) loan to the Metropolitan St. Louis Sewer District in Missouri to help finance its Deer Creek Sanitary Tunnel and Sanitary Relief project.